These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3545946

  • 1. Impaired insulin secretion associated with near normoglycemia. Study in normal rats with 96-h in vivo glucose infusions.
    Leahy JL, Cooper HE, Weir GC.
    Diabetes; 1987 Apr; 36(4):459-64. PubMed ID: 3545946
    [Abstract] [Full Text] [Related]

  • 2. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.
    Leahy JL, Cooper HE, Deal DA, Weir GC.
    J Clin Invest; 1986 Mar; 77(3):908-15. PubMed ID: 3512603
    [Abstract] [Full Text] [Related]

  • 3. Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level.
    Leahy JL, Weir GC.
    Diabetologia; 1991 Sep; 34(9):640-7. PubMed ID: 1955096
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of prolonged hyperglycemia on in vivo and in vitro insulin secretion in rats.
    Laury MC, Takao F, Bailbe D, Penicaud L, Portha B, Picon L, Ktorza A.
    Endocrinology; 1991 May; 128(5):2526-33. PubMed ID: 2019264
    [Abstract] [Full Text] [Related]

  • 5. Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia.
    van Haeften TW, Voetberg GA, Gerich JE, van der Veen EA.
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1059-64. PubMed ID: 2677037
    [Abstract] [Full Text] [Related]

  • 6. Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the nonobese diabetic (NOD) mouse.
    Kano Y, Kanatsuna T, Nakamura N, Kitagawa Y, Mori H, Kajiyama S, Nakano K, Kondo M.
    Diabetes; 1986 Apr; 35(4):486-90. PubMed ID: 3514327
    [Abstract] [Full Text] [Related]

  • 7. Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia.
    Leahy JL, Weir GC.
    Diabetes; 1988 Feb; 37(2):217-22. PubMed ID: 3292316
    [Abstract] [Full Text] [Related]

  • 8. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.
    Sako Y, Grill VE.
    Endocrinology; 1990 Oct; 127(4):1580-9. PubMed ID: 1698143
    [Abstract] [Full Text] [Related]

  • 9. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
    Rossetti L, Shulman GI, Zawalich W, DeFronzo RA.
    J Clin Invest; 1987 Oct; 80(4):1037-44. PubMed ID: 3308956
    [Abstract] [Full Text] [Related]

  • 10. Chronic in vivo hyperglycemia impairs phosphoinositide hydrolysis and insulin release in isolated perifused rat islets.
    Zawalich WS, Zawalich KC, Shulman GI, Rossetti L.
    Endocrinology; 1990 Jan; 126(1):253-60. PubMed ID: 2152864
    [Abstract] [Full Text] [Related]

  • 11. Effect of prolonged in vivo glucose infusion on insulin secretion in rats with previous glucose intolerance.
    Thibault C, Laury MC, Bailbe D, Ktorza A, Portha B.
    Endocrinology; 1992 May; 130(5):2521-7. PubMed ID: 1572279
    [Abstract] [Full Text] [Related]

  • 12. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
    Leahy JL, Bumbalo LM, Chen C.
    Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
    [Abstract] [Full Text] [Related]

  • 13. Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments.
    Serradas P, Bailbé D, Blondel O, Portha B.
    Pancreas; 1991 Jan; 6(1):54-62. PubMed ID: 1994380
    [Abstract] [Full Text] [Related]

  • 14. [Disparity between the effect of glucose and arginine on insulin secretion from the perfused pancreas of non insulin dependent diabetic rats].
    Giroix MH, Portha B, Kergoat M, Picon L.
    C R Seances Acad Sci III; 1981 Nov 16; 293(10):601-6. PubMed ID: 6800578
    [Abstract] [Full Text] [Related]

  • 15. Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.
    Novelli M, Pocai A, Lajoix AD, Beffy P, Bezzi D, Marchetti P, Gross R, Masiello P.
    Mol Cell Endocrinol; 2004 Apr 30; 219(1-2):77-82. PubMed ID: 15149729
    [Abstract] [Full Text] [Related]

  • 16. A continuous 48-hour glucose infusion in rats causes both an acute and a persistent redistribution of the blood flow within the pancreas.
    Styrud J, Eriksson UJ, Jansson L.
    Endocrinology; 1992 May 30; 130(5):2692-6. PubMed ID: 1572289
    [Abstract] [Full Text] [Related]

  • 17. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment.
    Leahy JL, Bonner-Weir S, Weir GC.
    Diabetes; 1985 Jul 30; 34(7):660-6. PubMed ID: 2408948
    [Abstract] [Full Text] [Related]

  • 18. Unresponsiveness to glucose in a streptozocin model of diabetes. Inappropriate insulin and glucagon responses to a reduction of glucose concentration.
    Leahy JL, Weir GC.
    Diabetes; 1985 Jul 30; 34(7):653-9. PubMed ID: 2861128
    [Abstract] [Full Text] [Related]

  • 19. Coupling of beta-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats.
    Sako Y, Grill VE.
    Diabetes; 1990 Dec 30; 39(12):1580-3. PubMed ID: 2245882
    [Abstract] [Full Text] [Related]

  • 20. Glucose intolerance in thyrotoxic rats: role of insulin, glucagon, and epinephrine.
    Ikeda T, Mokuda O, Tominaga M, Mashiba H.
    Am J Physiol; 1988 Dec 30; 255(6 Pt 1):E843-9. PubMed ID: 3059820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.